tiprankstipranks
Galderma Seizes Ozempic Face Opportunity
PremiumMarket NewsGalderma Seizes Ozempic Face Opportunity
8d ago
Eli Lilly price target raised to $875 from $825 at Wells Fargo
PremiumThe Fly
Eli Lilly price target raised to $875 from $825 at Wells Fargo
8d ago
Eli Lilly price target raised to $913 from $810 at Barclays
PremiumThe Fly
Eli Lilly price target raised to $913 from $810 at Barclays
8d ago
Eli Lilly raises FY24 adjusted EPS view to $13.50-$14.00 from $12.20-$12.70
PremiumThe FlyEli Lilly raises FY24 adjusted EPS view to $13.50-$14.00 from $12.20-$12.70
9d ago
Eli Lilly reports Q1 EPS $2.58, consensus $2.46
PremiumThe Fly
Eli Lilly reports Q1 EPS $2.58, consensus $2.46
9d ago
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
PremiumPress Releases
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
9d ago
LLY vs. JNJ: Which Big Pharma Stock Is Better?
PremiumMarket NewsLLY vs. JNJ: Which Big Pharma Stock Is Better?
14d ago
Eli Lilly (NYSE:LLY) Notches Up on New Manufacturing Plans
PremiumMarket News
Eli Lilly (NYSE:LLY) Notches Up on New Manufacturing Plans
17d ago
Influencers are talking up weight loss drugs, but omit side effects, WSJ says
PremiumThe Fly
Influencers are talking up weight loss drugs, but omit side effects, WSJ says
20d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100